Spanish Red Biotech Pipeline

Roche

CRENEZUMAB

Type: Biodrugs/ Drugs
Therapeutic area: Central Nervous System
Indication: Alzheimer's disease
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I